东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02348 东瑞制药

已收盘 11-06 15:38:47

0.910

-0.005

-0.55%

最高0.915	最低0.910	成交量38.00万
今开0.910	昨收0.915	日振幅0.55%
总市值13.69亿	流通市值13.69亿	总股本15.04亿
成交额34.63万	换手率0.03%	流通股本15.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02348","market":"HK","secType":"STK","nameCN":"东瑞制药","latestPrice":0.91,"timestamp":1793950727920,"preClose":0.915,"halted":0,"volume":380000,"delay":0,"changeRate":-0.005464480874316944,"floatShares":1504000000,"shares":1504000000,"eps":0.16454253234025873,"marketStatus":"已收盘","change":-0.005,"latestTime":"11-06 15:38:47","open":0.91,"high":0.915,"low":0.91,"amount":346300,"amplitude":0.005464,"askPrice":0.925,"askSize":48000,"bidPrice":0.905,"bidSize":152000,"shortable":0,"etf":0,"ttmEps":0.17912570192081534,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"listingDate":1057852800000,"exchange":"SEHK","adjPreClose":0.915,"dividendRate":0.069231,"openAndCloseTimeList":[[1793928600000,1793937600000],[1793941200000,1793952000000]],"volumeRatio":1.139089,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02348","defaultTab":"news","newsList":[{"id":"1112109550","title":"东瑞制药回购20万股股份，耗资约18.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112109550","media":"公告速递","labels":["SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112109550?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:02","pubTimestamp":1793955757,"startTime":"0","endTime":"0","summary":"东瑞制药于2026年11月6日发布公告，披露公司于同日通过香港联交所场内回购股份，共计回购20万股普通股，占当日公司已发行股本约0.0133%。每股回购价介乎港币0.91港元至0.915港元，合计动用资金约18.25万港元。回购后，公司已发行股本约15.03337亿股，库藏股约368.8万股，总股本维持15.07025亿股不变。公司同时确认已遵守香港联交所相关上市规则及适用法律的规管要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"东瑞制药回购20万股股份，耗资约18.25万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115779508","title":"东瑞制药回购24.8万股股份，涉资约22.71万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115779508","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115779508?lang=zh_cn&edition=full","pubTime":"2026-11-05 17:56","pubTimestamp":1793872594,"startTime":"0","endTime":"0","summary":"东瑞制药(控股)有限公司于2026年11月5日发布公告，披露公司于同日回购股份248,000股，占当时已发行股本约0.01649%。回购价格区间介乎每股0.91港元至0.92港元，总成交金额227,100港元，折合约22.71万港元。本次回购完成后，公司已发行股本变更为1,503,537,000股，库藏股份增至3,488,000股。公司强调上述回购行为符合香港联合交易所有限公司证券上市规则及相关法律规定。公告由公司秘书彭洁玲签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"东瑞制药回购24.8万股股份，涉资约22.71万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681040538","title":"东瑞制药(02348)11月5日斥资22.71万港元回购24.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681040538","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681040538?lang=zh_cn&edition=full","pubTime":"2026-11-05 17:52","pubTimestamp":1793872347,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药(02348)发布公告，于2026年11月5日，该公司斥资22.71万港元回购24.8万股股份，每股回购价0.91-0.92港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1519110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02348","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182623748","title":"东瑞制药11月4日回购21.2万股股份，总额约19.56万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182623748","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182623748?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:36","pubTimestamp":1793784978,"startTime":"0","endTime":"0","summary":"东瑞制药(控股)有限公司（股票代码：02348）于2026年11月4日公告称，当日于香港联交所场内回购212,000股普通股，占此前已发行股本约0.0141%。本次回购价格介乎每股0.915港元至0.925港元，合计支出约19.56万港元。\n本次回购后，公司已发行股本数量为1,503,785,000股，库藏股增至3,240,000股。根据公告内容，公司于2026年5月22日获得股东通过相关购回授权，可回购股份总数为150,562,700股。公司确认，本次回购已符合香港联交所《证券上市规则》及相关法律法规。该公告由公司秘书彭洁玲签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"东瑞制药11月4日回购21.2万股股份，总额约19.56万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680039620","title":"东瑞制药(02348)11月4日斥资19.56万港元回购21.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680039620","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680039620?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:35","pubTimestamp":1793784917,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药(02348)发布公告，于2026年11月4日斥资19.56万港元回购21.2万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518445.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02348","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133977478","title":"东瑞制药11月3日回购10万股股份，合计耗资约9.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133977478","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133977478?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:40","pubTimestamp":1793698847,"startTime":"0","endTime":"0","summary":"东瑞制药11月3日在香港联交所场内回购股份10万股，占回购前公司已发行股本的约0.00665%，每股回购价为0.925港元，合计耗资约9.25万港元。回购完成后，公司已发行股本由15.04097亿股降至15.03997亿股，库藏股增至302.8万股，总股本规模1,507,025,000股保持不变。根据公告，股东于2026年5月22日通过回购授权，公司可回购股份约1.505627亿股。本次回购后，公司股份将进入30天的暂止期，暂止期内公司将不会发行新股或出售、转让任何库藏股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"东瑞制药11月3日回购10万股股份，合计耗资约9.25万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103870785","title":"东瑞制药更新2026年10月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1103870785","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103870785?lang=zh_cn&edition=full","pubTime":"2026-11-02 19:23","pubTimestamp":1793618629,"startTime":"0","endTime":"0","summary":"东瑞制药于2026年11月2日发布2026年10月股份变动月报表。报告期为2026年10月1日至10月31日，法定股本和已发行股份总额整体保持稳定。根据公告，截至10月底，公司法定股本维持在200亿股，每股面值港币0.05元，注册股本总额为港币10亿元，与上月底持平。期末已发行股份总数为15.07025亿股，其中，已发行股份较上月底减少269.6万股，至15.04329亿股，同时库存股份增加269.6万股至269.6万股。相关回购股份已被列为库存股份，目前尚未注销。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136906966","title":"东瑞制药回购23.2万股股份，耗资约21.36万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136906966","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136906966?lang=zh_cn&edition=full","pubTime":"2026-11-02 19:22","pubTimestamp":1793618550,"startTime":"0","endTime":"0","summary":"2026年11月2日，东瑞制药(控股)有限公司发布公告，披露于香港联合交易所场内回购股份232,000股，约占公司于回购日前已发行股本的0.01542%。此次回购每股价格介乎港币0.915元至0.925元，总耗资约港币21.36万元。根据公告，前次股东大会已于2026年5月22日通过股份回购授权，公司可回购股份总数为150,562,700股，迄今已回购股份数为2,928,000股。公司确认本次股份回购行为符合香港联合交易所相关上市规则及适用法律规定。上述公告由公司秘书彭洁玲签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"东瑞制药回购23.2万股股份，耗资约21.36万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680375612","title":"东瑞制药(02348)11月2日斥资21.36万港元回购23.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680375612","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680375612?lang=zh_cn&edition=full","pubTime":"2026-11-02 19:21","pubTimestamp":1793618518,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药(02348)发布公告，于2026年11月2日，该公司斥资21.36万港元回购23.2万股股份，每股回购价0.915-0.925港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680142756","title":"东瑞制药(02348.HK)11月2日斥资21.36万港元回购23.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680142756","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680142756?lang=zh_cn&edition=full","pubTime":"2026-11-02 19:21","pubTimestamp":1793618518,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02348","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198728228","title":"东瑞制药回购128,000股股份，耗资约11.77万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198728228","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198728228?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:56","pubTimestamp":1793354209,"startTime":"0","endTime":"0","summary":"东瑞制药于2026年10月30日发布翌日披露报表，宣布公司当日于香港联交所场内回购普通股128,000股，占此前已发行股本约0.00851%，每股回购价介乎0.915港元至0.92港元，合计支付约11.77万港元。回购授权于2026年5月22日获股东大会批准，授权总数为150,562,700股，截至目前公司已在香港联交所及其他交易所合计回购2,696,000股，约占授权通过日已发行股份数目的0.17906%。公司确认本次回购符合香港联交所上市规则及相关法律条文。本公告由公司秘书彭洁玲签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"东瑞制药回购128,000股股份，耗资约11.77万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679916572","title":"东瑞制药(02348)10月30日斥资11.77万港元回购12.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679916572","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679916572?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:53","pubTimestamp":1793354001,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药(02348)发布公告，于2026年10月30日斥资11.77万港元回购12.8万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1516233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167782771","title":"东瑞制药10月29日回购44,000股，耗资约4.05万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167782771","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167782771?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:26","pubTimestamp":1793265961,"startTime":"0","endTime":"0","summary":"东瑞制药于2026年10月29日公告，已于当日在香港联交所场内回购普通股44,000股，占回购前公司已发行股本约0.00292%。回购价格为每股0.92港元，合计动用资金约40,480港元。公司回购授权于2026年5月22日通过，授权可回购股份总数为150,562,700股，截至本次回购后已回购数量累计达2,568,000股。公司同时表示，此次回购严格遵守香港联交所相关上市规则及适用法律规定。公告由公司秘书彭洁玲签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"东瑞制药10月29日回购44,000股，耗资约4.05万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195977983","title":"东瑞制药回购404,000股股份，涉资约37.83万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195977983","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195977983?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:46","pubTimestamp":1793180801,"startTime":"0","endTime":"0","summary":"东瑞制药(控股)有限公司于2026年10月28日发布翌日披露报表，宣布当日于香港联交所场内回购普通股404,000股，占当日公司既有已发行股本约0.02685%。此次回购的每股价格介乎0.93港元至0.94港元，合计耗资约37.83万港元。回购完成后，公司已发行股份总数维持1,507,025,000股，其中已发行股份减少至1,504,501,000股，库存股份增至2,524,000股。公司于2026年5月22日获股东大会通过回购授权，可回购股份总数为150,562,700股。公司方面确认已遵守香港联合交易所有限公司的相关上市规则。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"东瑞制药回购404,000股股份，涉资约37.83万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678745716","title":"东瑞制药(02348.HK)10月28日斥资37.83万港元回购40.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678745716","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678745716?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:42","pubTimestamp":1793180539,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02348","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128723685","title":"东瑞制药10月27日回购21.6万股股份，耗资约20.22万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128723685","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128723685?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:46","pubTimestamp":1793094387,"startTime":"0","endTime":"0","summary":"东瑞制药(控股)有限公司于2026年10月27日发布公告，宣布当日于香港联交所场内回购股份。公司回购股份数量为21.60万股，占回购前已发行股本约0.01435%，每股回购价介乎0.93港元至0.95港元，合计耗资约20.22万港元。此次购回行为依据公司于2026年5月22日通过的购回授权进行，该授权可回购股份总数约为1.51亿股，公司截至目前已于证券交易所合计回购股份212.00万股，占授权时已发行股本的约0.14081%。公司在公告中确认已遵守香港联交所证券上市规则及相关法例规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"东瑞制药10月27日回购21.6万股股份，耗资约20.22万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678996127","title":"东瑞制药(02348)10月27日斥资20.22万港元回购21.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678996127","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678996127?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:41","pubTimestamp":1793094094,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药(02348)发布公告，于2026年10月27日，该公司斥资20.22万港元回购21.6万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194191938","title":"东瑞制药回购32.40万股股份，耗资约30.46万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194191938","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194191938?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:27","pubTimestamp":1793006842,"startTime":"0","endTime":"0","summary":"东瑞制药于2026年10月26日发布公告，披露已于当日在香港联交所场内回购普通股32.40万股，占回购前公司已发行股本约0.02152%。本次回购每股价格介乎0.93港元至0.945港元之间，共耗资约30.46万港元。公司于2026年5月22日通过购回授权，总计可购回的股份数量为150,562,700股。截至公告日，已回购股份数量累计达1,904,000股，占购回授权当日已发行股本约0.12646%。东瑞制药在公告中确认，已严格遵守香港联合交易所有限公司的相关上市规则及适用法规。公告由公司秘书彭洁玲签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"东瑞制药回购32.40万股股份，耗资约30.46万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678088165","title":"东瑞制药(02348)10月26日耗资约30.46万港元回购32.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678088165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678088165?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:18","pubTimestamp":1793006318,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药(02348)公布，2026年10月26日耗资约30.46万港元回购32.4万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185109193","title":"东瑞制药10月23日回购23.6万股股份，耗资约22.32万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185109193","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185109193?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:00","pubTimestamp":1792749652,"startTime":"0","endTime":"0","summary":"东瑞制药于2026年10月23日回购23.6万股股份，占当日回购前公司已发行股本约0.01567%。本次回购均于香港联交所场内进行，每股回购价格介乎每股0.94港元至0.95港元，总耗资约22.32万港元。\n回购完成后，公司已发行股本变动为15.05445亿股，该次交易使公司库藏股数增至158万股。上述回购根据2026年5月22日通过的购回授权进行，该授权允许购回的股份总数为1.505627亿股，而目前已于香港联交所或其他证券交易所合计回购的股份数为158万股。\n公司确认，此次回购严格遵守香港联交所证券上市规则及相关法律规定。公告由公司秘书彭洁玲女士签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"东瑞制药10月23日回购23.6万股股份，耗资约22.32万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dawnrays.com","stockEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.0518},{"period":"3month","weight":-0.0711},{"period":"6month","weight":-0.148},{"period":"1year","weight":-0.1764},{"period":"ytd","weight":-0.2037}],"compareEarnings":[{"period":"1week","weight":0.0801},{"period":"1month","weight":0.0213},{"period":"3month","weight":-0.0339},{"period":"6month","weight":-0.0605},{"period":"1year","weight":-0.0439},{"period":"ytd","weight":-0.0325}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"东瑞制药（控股）有限公司是一家主要从事非专利药物的开发、制造及销售业务的投资控股公司。该公司通过两个部门运营业务。成药分部从事制造及销售成药。中间体及原料药分部从事制造及销售中间体及原料药。","yearOnYearQuotes":[{"month":1,"riseRate":0.478261,"avgChangeRate":0.000418},{"month":2,"riseRate":0.478261,"avgChangeRate":-0.004351},{"month":3,"riseRate":0.478261,"avgChangeRate":0.01752},{"month":4,"riseRate":0.695652,"avgChangeRate":0.037866},{"month":5,"riseRate":0.478261,"avgChangeRate":0.017383},{"month":6,"riseRate":0.565217,"avgChangeRate":0.00718},{"month":7,"riseRate":0.565217,"avgChangeRate":0.018527},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.018216},{"month":9,"riseRate":0.458333,"avgChangeRate":0.020152},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.003972},{"month":11,"riseRate":0.541667,"avgChangeRate":0.034558},{"month":12,"riseRate":0.565217,"avgChangeRate":0.012921}],"exchange":"SEHK","name":"东瑞制药","nameEN":"DAWNRAYS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东瑞制药,02348,东瑞制药股票,东瑞制药股票老虎,东瑞制药股票老虎国际,东瑞制药行情,东瑞制药股票行情,东瑞制药股价,东瑞制药股市,东瑞制药股票价格,东瑞制药股票交易,东瑞制药股票购买,东瑞制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}